SCHEMBL7145366

SCHEMBL7145366

CC(=O)S[C@@H]1CC(C(=O)OC(C)(C)C)N(S(=O)(=O)c2ccc3ccccc3c2)C1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MME P08473 2/20 0.42
ACE P12821 2/20 0.42
ECE1 P42892 2/20 0.42
CASP3 P42574 1/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
ACACB O00763 1/20 0.41
AKR1C3 P42330 3/20 0.40
AKR1C1 Q04828 1/20 0.40
CCR4 P51679 3/20 0.40
MCL1 Q07820 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.38
KMT2A Q03164 2/20 0.38
PKM P14618 2/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7137614 1.00 MME (0.42) MMEACEECE1CASP3LMNA
SCHEMBL7143280 0.90 MME (0.46) MMEACEECE1LMNAALDH1A1
SCHEMBL7144003 0.90 MME (0.46) MMEACEECE1LMNAALDH1A1
SCHEMBL7143089 0.90 MME (0.46) MMEACEECE1LMNAALDH1A1
SCHEMBL7143783 0.90 MME (0.46) MMEACEECE1LMNAALDH1A1
SCHEMBL7144626 0.86 AKR1C3 (0.48) MMEACEECE1LMNAALDH1A1
SCHEMBL7148996 0.85 ALDH1A1 (0.48) MMEACEECE1CASP3LMNA
SCHEMBL7143312 0.85 ALDH1A1 (0.48) MMEACEECE1CASP3LMNA
SCHEMBL7141875 0.82 MME (0.42) MMEACEECE1CASP3LMNA
SCHEMBL7148874 0.82 MME (0.42) MMEACEECE1CASP3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303485-A1 PYRROLIDINE DERIVATIVES AS INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
WO-2002006222-A1 PYRROLIDINE DERIVATIVES AS INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 WO disclosed